如果您要报告不良事件或产品投诉,请拨打礼来客户服务中心热线400-828-2059(手机),800-828-2059(座机)
中轴型脊柱关节炎患者停药后依奇珠单抗再获得应答比例和再治疗率：随机安慰剂对照停药研究的第 104 周结果
返回Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study
作者:Robert B M Landewé, Denis Poddubnyy, Proton Rahman, Filip E Van den Bosch, Rebecca Bolce, Soyi Liu Leage, Jeffrey R Lisse, So Young Park, Lianne Gensler期刊:Annals of Rheumatic Diseases发表日期:9/13/2022卷/期/页码:Online First
